化合物FPFT-2216 T60608
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mg | 2367619-87-0 | ¥1,299.00 | 询底价 |
Product Introduction
Bioactivity
英文名: FPFT-2216
描述: FPFT-2216 是一种分子胶,可降解 IKZF6、IKZF1、DE1D 和 CK3α。FPFT-2216 具有潜在的抗肿瘤活性,可用于研究免疫系统疾病。
体外活性: FPFT-2216 (1 μM; 5 hours) not only degrades its known targets IKZF1, IKZF3, and CK1α in MOLT4 cells but also demonstrates the degradation of PDE6D[2].FPFT-2216 (1 μM; 0 h, 2 h, 4 h, 6 h, 16 h, 24 h) shows complete degradation of PDE6D within 2 hours, and the degradation of PDE6D persists for at least 24 hours in MOLT4 cells[1].FPFT-2216 (0 nM, 1.6 nM, 8 nM, 40 nM, 200 nM, 1 μM; 4 hours) exhibits over 50% degradation of PDE6D at the dose of 8 nM, with maximal degradation of PDE6D, IKZF1, IKZF3, and CK1α observed at the dose of 200 nM in MOLT4 cells[2].FPFT-2216 does not impede the growth of KRASG12C-dependent MIA PaCa-2 cells[1].FPFT-2216 (10, 20, 40 μM; 14 or 24 hours) significantly upregulates IL-2, although its effect in naive CD4+ T cells is less potent than Pomalidomide[2].FPFT-2216 (10 μM; 14 or 24 hours) degrades the immune modulatory drug (IMiD) ubiquitin-proteasome degradation substrates IKZF1 and CK-1α in naive CD4+ T cells[1].
体内活性: FPFT-2216(30 mg/kg;口服或腹腔注射)在CRBNI391V小鼠中显著促进CK-1α和IKZF1的降解[1]。
存储条件: store at low temperaturePowder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 20 mg/mL (68.42 mM)
相关产品: Longdaysin | LH846 | NCC007 | MLN8054 | AS-252424 | PF-5006739 | Ac-ESMD-CHO | LY-364947 | XL413 hydrochloride | BMS-863233 HCl
化合物FPFT-2216 T60608信息由TargetMol中国为您提供,如您想了解更多关于化合物FPFT-2216 T60608报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途